Cargando…
Nestin and collagen triple helix repeat containing 1 in breast cancer progression
Autores principales: | Kharaishvili, G, Simkova, D, Cizkova, M, Bouchalova, K, Mgebrishvili, G, Kolar, Z, Bouchal, J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247051/ http://dx.doi.org/10.1186/bcr3024 |
Ejemplares similares
-
BCL2 is a predictive marker of adjuvant CMF regimen in triple-negative breast cancer patients
por: Bouchalova, K, et al.
Publicado: (2011) -
The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance
por: Kharaishvili, Gvantsa, et al.
Publicado: (2014) -
Collagen triple helix repeat containing 1 is a new promigratory marker of arthritic pannus
por: Shekhani, Mohammed Talha, et al.
Publicado: (2016) -
Multidimensional Roles of Collagen Triple Helix Repeat Containing 1 (CTHRC1) in Malignant Cancers
por: Jiang, Neng, et al.
Publicado: (2016) -
The Role of Collagen Triple Helix Repeat-Containing 1 Protein (CTHRC1) in Rheumatoid Arthritis
por: Myngbay, Askhat, et al.
Publicado: (2021)